Sedative, hypnotic or anxiolytic abuse with withdrawal, unspecified
ICD-10 F13.139 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic abuse with withdrawal, unspecified.
F13.139 refers to the abuse of sedative, hypnotic, or anxiolytic substances, which are commonly used to treat anxiety and sleep disorders. This code specifically indicates that the individual is experiencing withdrawal symptoms due to the cessation of these substances. Withdrawal symptoms can include anxiety, tremors, insomnia, and seizures, depending on the substance and duration of use. The unspecified aspect of this code indicates that the specific substance causing the abuse and withdrawal is not documented. Clinically, this condition is part of a broader category of substance use disorders, which can lead to significant impairment in social, occupational, or other important areas of functioning. Treatment often involves a combination of medical detoxification, psychological support, and rehabilitation programs aimed at addressing both the physical and psychological aspects of addiction. Understanding the nuances of this code is crucial for accurate documentation and appropriate treatment planning.
Detailed history of substance use, withdrawal symptoms, and treatment plans.
Patients presenting with withdrawal symptoms after cessation of sedatives or anxiolytics.
Consideration of co-occurring mental health disorders and comprehensive treatment approaches.
Thorough psychiatric evaluation, including mental status examination and substance use history.
Patients with anxiety disorders who misuse sedatives or anxiolytics.
Assessment of underlying psychiatric conditions that may contribute to substance abuse.
Used during initial evaluation of a patient presenting with withdrawal symptoms.
Comprehensive assessment notes detailing the patient's history and current symptoms.
Addiction specialists may require additional documentation regarding substance use history.
Document the patient's history of substance use, specific withdrawal symptoms experienced, and any treatment interventions initiated to support the diagnosis.
